Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
65% of
#clinicaltrial professionals are asked to do more with less leading to an impact on oversight responsibilities http://bit.ly/2GABGjP pic.twitter.com/kv1lgsuiJm
-
Follow the trends in robotic process automation (RPA) in
#pharma and#medtech with this free#whitepaper. Download here http://bit.ly/30HdINk pic.twitter.com/sOxzWnsJfP
-
The
#medtech industry has adpated its business model to focus more on patient outcomes, cost-efficiency and quality of care? But what more can#medtech do? Find out in this in-dpeth whitepaper here http://bit.ly/2REsctb pic.twitter.com/8GC3nKG9um
-
With the number of confirmed deaths increasing every day, what impact will the Coronavirus have? http://bit.ly/37LVMUq pic.twitter.com/4SQzi1hm1t
-
Learn how advances in automation are transforming process in
#lifesciences industries in our latest#whitepaper. Donwload here http://bit.ly/2Ge9eEr pic.twitter.com/QUhTTY0Fvh
-
Senior pharma industry executives gathered in London last November to discuss the future of the pharma sector. These were their findings. Download your copy here http://bit.ly/314HsE6 pic.twitter.com/EsZnov3QtU
-
Click to access our inspiring
#DIA2020 Overview Video and get a feel for the conference. http://bit.ly/2TJo25S pic.twitter.com/nKVN8ZBfgp
-
Are you a
#gastroentrologist or work within the#NHS? Click to access our On Demand#webinar on a Inflammatory Bowel Disease Update. http://bit.ly/2RjOUaX pic.twitter.com/lbxNU3rROn
-
Understand the challenges of increasing
#clinicaltrial complexity and how they impact oversight responsibilities with this detailed#infographic here http://bit.ly/3aQgzIv pic.twitter.com/QZqoQKkpIB
-
Will cutting through the noise of data help you make more rapid and informed decisions around clinical trials? Learn more about a 3-part solution for
#ClinicalTrial Oversight here http://bit.ly/36BAUhc pic.twitter.com/VL2ieDiF5C
-
In a recent roundtable event, drug manufacturing experts met to discuss the over value of patient-centric formulations, & more. Learn more about these discussions here http://bit.ly/2O4DHsY pic.twitter.com/Y0a2cnwcVD
-
Get expert analysis of the biggest news to come out of
#ASH2019. Find out more in our report extract here http://bit.ly/36BPvck pic.twitter.com/CzwZas4trm
-
According to a recent survey by
#NTTDATA, patient awareness & access were the largest obstacles to enrollment in precision-based#clinicaltrials. Register for our#webinar to learn more http://bit.ly/2RjIEQo pic.twitter.com/RMjxq9kdnp
-
Wondering how you will fill your pipeline & hit your sales numbers in 2020? By partnering with
#PharmaIntelligence, you can generate high quality leads, fill your pipeline & create bespoke#thoughtleadership. Find out more here http://bit.ly/3aX0z7h pic.twitter.com/tlddDIiwmq
-
[WHITEPAPER] New Frontiers for Innovation and Value in Medtech. Download your copy here http://bit.ly/38wzia0 pic.twitter.com/gjeYAqss73
-
It is that time of year again! It is time to vote in the 12th annual
#DealsOfTheYear contest! We have chosen 15 nominees across 3 categories: Financing, M&A & Alliance. Caste your vote here http://bit.ly/2Gy4Ro0 pic.twitter.com/6MkuDxXBtb
-
[eBook] The 15th Annual
#ScripAwards 2019. Take a look at the honor roll from last years' awards ceremony http://bit.ly/2GhlCmV pic.twitter.com/d5B4r5PVeA
-
The battle lines are starting to blur between
#BigPharma &#Generics & could this competitor industry be a potential partner? Find out in this article here http://bit.ly/2GwdAqI pic.twitter.com/zJddZAvs6d
-
#ClinicalTrials are becoming increasingly complex resulting in increased trial oversight workloads. Download the findings of a recent study conducted by#Medidata & learn more http://bit.ly/36A3506 pic.twitter.com/oiaWgg7Kda
-
Did you know that 81% of survey respondents experienced some type of increased workload related to
#clinicaltrial oversight? Learn more in our#infographic http://bit.ly/37AE4D5 pic.twitter.com/wr4duGqbrT
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.